ArticleThe Journal of infectious diseases2024

Correction to: Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study.

No numbers read from the abstract.

Not cited yet